Aberrant Protein S-nitrosylation in neurodegenerative diseases

Neuron

Volumn 78, Issue 4, 2013, Pages 596-614

  Nakamura, Tomohiro ^a   Tu, Shichun ^a   Akhtar, MohdWaseem ^a   Sunico, CarmenR ^a   Okamoto, Shu ichi ^a   Lipton, StuartA ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CASPASE; CELL PROTEIN; CYCLIN DEPENDENT KINASE 5; CYCLOOXYGENASE 2; CYSTEINE; DJ 1 PROTEIN; DRP1 PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; I KAPPA B KINASE BETA; INSULINASE; IRON; JNK1 PROTEIN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 5; NITRIC OXIDE; PARKIN; PDI PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; PRX2 PROTEIN; REGULATOR PROTEIN; THIOL; TOXIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

AGING; ALZHEIMER DISEASE; APOPTOSIS; AUTOPHAGY; COVALENT BOND; DEGENERATIVE DISEASE; ENVIRONMENTAL FACTOR; HUMAN; IRON METABOLISM; MITOCHONDRION; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN S NITROSYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

ANIMALS; BRAIN; HUMANS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES;

EID: 84878443676     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.05.005     Document Type: Review

References (193)

1. Abrams A.J., Farooq A., Wang G. S-nitrosylation of ApoE in Alzheimer's disease. Biochemistry 2011, 50:3405-3407.
2. Akhand A.A., Pu M., Senga T., Kato M., Suzuki H., Miyata T., Hamaguchi M., Nakashima I. Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J.Biol. Chem. 1999, 274:25821-25826.
3. Asada K., Kurokawa J., Furukawa T. Redox- and calmodulin-dependent S-nitrosylation of the KCNQ1 channel. J.Biol. Chem. 2009, 284:6014-6020.
4. Azad N., Vallyathan V., Wang L., Tantishaiyakul V., Stehlik C., Leonard S.S., Rojanasakul Y. S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. J.Biol. Chem. 2006, 281:34124-34134.
5. Bae B.I., Hara M.R., Cascio M.B., Wellington C.L., Hayden M.R., Ross C.A., Ha H.C., Li X.J., Snyder S.H., Sawa A. Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH. Proc. Natl. Acad. Sci. USA 2006, 103:3405-3409.
6. Banerjee S., Liao L., Russo R., Nakamura T., McKercher S.R., Okamoto S., Haun F., Nikzad R., Zaidi R., Holland E., et al. Isobaric tagging-based quantification by mass spectrometry of differentially regulated proteins in synaptosomes of HIV/gp120 transgenic mice: implications for HIV-associated neurodegeneration. Exp. Neurol. 2012, 236:298-306.
7. Barglow K.T., Knutson C.G., Wishnok J.S., Tannenbaum S.R., Marletta M.A. Site-specific and redox-controlled S-nitrosation of thioredoxin. Proc. Natl. Acad. Sci. USA 2011, 108:E600-E606.
8. Barrett D.M., Black S.M., Todor H., Schmidt-Ullrich R.K., Dawson K.S., Mikkelsen R.B. Inhibition of protein-tyrosine phosphatases by mild oxidative stresses is dependent on S-nitrosylation. J.Biol. Chem. 2005, 280:14453-14461.
9. Batelli S., Albani D., Rametta R., Polito L., Prato F., Pesaresi M., Negro A., Forloni G. DJ-1 modulates α-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70. PLoS ONE 2008, 3:e1884.
10. Beal M.F. Experimental models of Parkinson's disease. Nat. Rev. Neurosci. 2001, 2:325-334.
11. Benhar M., Forrester M.T., Hess D.T., Stamler J.S. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 2008, 320:1050-1054.
12. Benhar M., Forrester M.T., Stamler J.S. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat. Rev. Mol. Cell Biol. 2009, 10:721-732.
13. Bertram L., Lill C.M., Tanzi R.E. The genetics of Alzheimer disease: back to the future. Neuron 2010, 68:270-281.
14. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000, 3:1301-1306.
15. Blackinton J., Lakshminarasimhan M., Thomas K.J., Ahmad R., Greggio E., Raza A.S., Cookson M.R., Wilson M.A. Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J.Biol. Chem. 2009, 284:6476-6485.
16. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 1995, 92:7162-7166.
17. Bonifati V. Autosomal recessive parkinsonism. Parkinsonism Relat. Disord. 2012, 18(Suppl 1):S4-S6.
18. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C.J., Squitieri F., Ibanez P., Joosse M., et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
19. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991, 351:714-718.
20. Brenman J.E., Chao D.S., Gee S.H., McGee A.W., Craven S.E., Santillano D.R., Wu Z., Huang F., Xia H., Peters M.F., et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 1996, 84:757-767.
21. Brown G.C., Borutaite V. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim. Biophys. Acta 2004, 1658:44-49.
22. Burwell L.S., Nadtochiy S.M., Tompkins A.J., Young S., Brookes P.S. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem. J. 2006, 394:627-634.
23. Chakravarti R., Aulak K.S., Fox P.L., Stuehr D.J. GAPDH regulates cellular heme insertion into inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA 2010, 107:18004-18009.
24. Chanvorachote P., Nimmannit U., Wang L., Stehlik C., Lu B., Azad N., Rojanasakul Y. Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein. J.Biol. Chem. 2005, 280:42044-42050.
25. Cheah J.H., Kim S.F., Hester L.D., Clancy K.W., Patterson S.E., Papadopoulos V., Snyder S.H. NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 2006, 51:431-440.
26. Chen Y., Dorn G.W. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 2013, 340:471-475.
27. 2+) channels constituting a putative positive feedback loop. Free Radic. Biol. Med. 2002, 32:638-649.
28. Chen Y.Y., Chu H.M., Pan K.T., Teng C.H., Wang D.L., Wang A.H., Khoo K.H., Meng T.C. Cysteine S-nitrosylation protects protein-tyrosine phosphatase 1B against oxidation-induced permanent inactivation. J.Biol. Chem. 2008, 283:35265-35272.
29. Chen X., Guan T., Li C., Shang H., Cui L., Li X.M., Kong J. SOD1 aggregation in astrocytes following ischemia/reperfusion injury: a role of NO-mediated S-nitrosylation of protein disulfide isomerase (PDI). J.Neuroinflammation 2012, 9:237.
30. Chen X., Zhang X., Li C., Guan T., Shang H., Cui L., Li X.M., Kong J. S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis. J.Neurochem. 2013, 124:45-58.
31. Cheung Z.H., Ip N.Y. Cdk5: a multifaceted kinase in neurodegenerative diseases. Trends Cell Biol. 2012, 22:169-175.
32. Cho D.H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., Lipton S.A. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
33. Choi Y.B., Tenneti L., Le D.A., Ortiz J., Bai G., Chen H.S., Lipton S.A. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat. Neurosci. 2000, 3:15-21.
34. 2+ modulation of the nmda receptor. J.Neurosci. 2001, 21:392-400.
35. Chung K.K., Thomas B., Li X., Pletnikova O., Troncoso J.C., Marsh L., Dawson V.L., Dawson T.M. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 2004, 304:1328-1331.
36. Cleeter M.W., Cooper J.M., Darley-Usmar V.M., Moncada S., Schapira A.H. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 1994, 345:50-54.
37. Clementi E., Brown G.C., Feelisch M., Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Natl. Acad. Sci. USA 1998, 95:7631-7636.
38. Conn K.J., Gao W., McKee A., Lan M.S., Ullman M.D., Eisenhauer P.B., Fine R.E., Wells J.M. Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Res. 2004, 1022:164-172.
39. Cordes C.M., Bennett R.G., Siford G.L., Hamel F.G. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation. Biochem. Pharmacol. 2009, 77:1064-1073.
40. da Costa C.A., Sunyach C., Giaime E., West A., Corti O., Brice A., Safe S., Abou-Sleiman P.M., Wood N.W., Takahashi H., et al. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat. Cell Biol. 2009, 11:1370-1375.
41. Dahm C.C., Moore K., Murphy M.P. Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J.Biol. Chem. 2006, 281:10056-10065.
42. Dall'Agnol M., Bernstein C., Bernstein H., Garewal H., Payne C.M. Identification of S-nitrosylated proteins after chronic exposure of colon epithelial cells to deoxycholate. Proteomics 2006, 6:1654-1662.
43. Dawson T.M., Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003, 302:819-822.
44. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 1991, 88:6368-6371.
45. Dawson T.M., Ko H.S., Dawson V.L. Genetic animal models of Parkinson's disease. Neuron 2010, 66:646-661.
46. Deveraux Q.L., Leo E., Stennicke H.R., Welsh K., Salvesen G.S., Reed J.C. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 1999, 18:5242-5251.
47. Dimmeler S., Haendeler J., Nehls M., Zeiher A.M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J.Exp. Med. 1997, 185:601-607.
48. Doulias P.T., Greene J.L., Greco T.M., Tenopoulou M., Seeholzer S.H., Dunbrack R.L., Ischiropoulos H. Structural profiling of endogenous S-nitrosocysteine residues reveals unique features that accommodate diverse mechanisms for protein S-nitrosylation. Proc. Natl. Acad. Sci. USA 2010, 107:16958-16963.
49. Drapier J.C., Hibbs J.B. Differentiation of murine macrophagesto express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J.Immunol. 1988, 140:2829-2838.
50. Eckelman B.P., Salvesen G.S., Scott F.L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 2006, 7:988-994.
51. 2 sensor and NO signaling functions. Cell 2000, 102:499-509.
52. Fang M., Jaffrey S.R., Sawa A., Ye K., Luo X., Snyder S.H. Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 2000, 28:183-193.
53. Fang J., Nakamura T., Cho D.-H., Gu Z., Lipton S.A. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc. Natl. Acad. Sci. USA 2007, 104:18742-18747.
54. Finkel T. Signal transduction by reactive oxygen species. J.Cell Biol. 2011, 194:7-15.
55. Forrester M.T., Thompson J.W., Foster M.W., Nogueira L., Moseley M.A., Stamler J.S. Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat. Biotechnol. 2009, 27:557-559.
56. Förstermann U., Schmidt H.H., Pollock J.S., Sheng H., Mitchell J.A., Warner T.D., Nakane M., Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem. Pharmacol. 1991, 42:1849-1857.
57. 2 involves KEAP1 disulfide formation. J.Biol. Chem. 2010, 285:8463-8471.
58. Garbán H.J., Márquez-Garbán D.C., Pietras R.J., Ignarro L.J. Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc. Natl. Acad. Sci. USA 2005, 102:2632-2636.
59. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., Smith J.W., Liddington R.C., Lipton S.A. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002, 297:1186-1190.
60. Hao G., Derakhshan B., Shi L., Campagne F., Gross S.S. SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. Proc. Natl. Acad. Sci. USA 2006, 103:1012-1017.
61. Hara M.R., Agrawal N., Kim S.F., Cascio M.B., Fujimuro M., Ozeki Y., Takahashi M., Cheah J.H., Tankou S.K., Hester L.D., et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat. Cell Biol. 2005, 7:665-674.
62. Hara M.R., Thomas B., Cascio M.B., Bae B.-I., Hester L.D., Dawson V.L., Dawson T.M., Sawa A., Snyder S.H. Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc. Natl. Acad. Sci. USA 2006, 103:3887-3889.
63. Hardingham G.E., Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 2010, 11:682-696.
64. Harris L.K., McCormick J., Cartwright J.E., Whitley G.S., Dash P.R. S-nitrosylation of proteins at the leading edge of migrating trophoblasts by inducible nitric oxide synthase promotes trophoblast invasion. Exp. Cell Res. 2008, 314:1765-1776.
65. Hess D.T., Patterson S.I., Smith D.S., Skene J.H. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 1993, 366:562-565.
66. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., Stamler J.S. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 2005, 6:150-166.
67. Ho G.P., Selvakumar B., Mukai J., Hester L.D., Wang Y., Gogos J.A., Snyder S.H. S-nitrosylation and S-palmitoylation reciprocally regulate synaptic targeting of PSD-95. Neuron 2011, 71:131-141.
68. Hu R.G., Sheng J., Qi X., Xu Z., Takahashi T.T., Varshavsky A. The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature 2005, 437:981-986.
69. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994, 265:1883-1885.
70. Huang Y., Man H.Y., Sekine-Aizawa Y., Han Y., Juluri K., Luo H., Cheah J., Lowenstein C., Huganir R.L., Snyder S.H. S-nitrosylation of N-ethylmaleimide sensitive factor mediates surface expression of AMPA receptors. Neuron 2005, 46:533-540.
71. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 1992, 298:431-437.
72. Ito G., Ariga H., Nakagawa Y., Iwatsubo T. Roles of distinct cysteine residues in S-nitrosylation and dimerization of DJ-1. Biochem. Biophys. Res. Commun. 2006, 339:667-672.
73. Jaffrey S.R., Fang M., Snyder S.H. Nitrosopeptide mapping: a novel methodology reveals s-nitrosylation of dexras1 on a single cysteine residue. Chem. Biol. 2002, 9:1329-1335.
74. Jia J., Arif A., Willard B., Smith J.D., Stuehr D.J., Hazen S.L., Fox P.L. Protection of extraribosomal RPL13a by GAPDH and dysregulation by S-nitrosylation. Mol. Cell 2012, 47:656-663.
75. Kakizawa S., Yamazawa T., Chen Y., Ito A., Murayama T., Oyamada H., Kurebayashi N., Sato O., Watanabe M., Mori N., et al. Nitric oxide-induced calcium release via ryanodine receptors regulates neuronal function. EMBO J. 2012, 31:417-428.
76. Kang-Decker N., Cao S., Chatterjee S., Yao J., Egan L.J., Semela D., Mukhopadhyay D., Shah V. Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2. J.Cell Sci. 2007, 120:492-501.
77. Kapadia M.R., Eng J.W., Jiang Q., Stoyanovsky D.A., Kibbe M.R. Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells. Nitric Oxide 2009, 20:279-288.
78. Kim S., Wing S.S., Ponka P. S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway. Mol. Cell. Biol. 2004, 24:330-337.
79. Kim R.H., Smith P.D., Aleyasin H., Hayley S., Mount M.P., Pownall S., Wakeham A., You-Ten A.J., Kalia S.K., Horne P., et al. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. USA 2005, 102:5215-5220.
80. Kim S.F., Huri D.A., Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 2005, 310:1966-1970.
81. Kim Y., Sung J.Y., Ceglia I., Lee K.-W., Ahn J.-H., Halford J.M., Kim A.M., Kwak S.P., Park J.B., Ho Ryu S., et al. Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature 2006, 442:814-817.
82. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
83. Knott A.B., Perkins G., Schwarzenbacher R., Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 2008, 9:505-518.
84. Kornberg M.D., Sen N., Hara M.R., Juluri K.R., Nguyen J.V., Snowman A.M., Law L., Hester L.D., Snyder S.H. GAPDH mediates nitrosylation of nuclear proteins. Nat. Cell Biol. 2010, 12:1094-1100.
85. Krapfenbauer K., Engidawork E., Cairns N., Fountoulakis M., Lubec G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res. 2003, 967:152-160.
86. Kwak Y.D., Ma T., Diao S., Zhang X., Chen Y., Hsu J., Lipton S.A., Masliah E., Xu H., Liao F.F. NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration. Mol. Neurodegener. 2010, 5:49.
87. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993, 364:535-537.
88. Lander H.M., Ogiste J.S., Pearce S.F., Levi R., Novogrodsky A. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J.Biol. Chem. 1995, 270:7017-7020.
89. LaVaute T., Smith S., Cooperman S., Iwai K., Land W., Meyron-Holtz E., Drake S.K., Miller G., Abu-Asab M., Tsokos M., et al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 2001, 27:209-214.
90. 2. J.Biol. Chem. 2002, 277:20336-20342.
91. Lee S.B., Kim C.K., Lee K.H., Ahn J.Y. S-nitrosylation of B23/nucleophosmin by GAPDH protects cells from the SIAH1-GAPDH death cascade. J.Cell Biol. 2012, 199:65-76.
92. Lei S.Z., Pan Z.-H., Aggarwal S.K., Chen H.-S.V., Hartman J., Sucher N.J., Lipton S.A. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 1992, 8:1087-1099.
93. Li L., Liu F., Salmonsen R.A., Turner T.K., Litofsky N.S., Di Cristofano A., Pandolfi P.P., Jones S.N., Recht L.D., Ross A.H. PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation. Mol. Cell. Neurosci. 2002, 20:21-29.
94. Li Z., Okamoto K., Hayashi Y., Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119:873-887.
95. Li F., Sonveaux P., Rabbani Z.N., Liu S., Yan B., Huang Q., Vujaskovic Z., Dewhirst M.W., Li C.Y. Regulation of HIF-1α stability through S-nitrosylation. Mol. Cell 2007, 26:63-74.
96. Li C., Feng J.J., Wu Y.P., Zhang G.Y. Cerebral ischemia-reperfusion induces GAPDH S-nitrosylation and nuclear translocation. Biochemistry (Mosc.) 2012, 77:671-678.
97. Liberatore G.T., Jackson-Lewis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., Dawson V.L., Dawson T.M., Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 1999, 5:1403-1409.
98. Lindholm D., Wootz H., Korhonen L. ER stress and neurodegenerative diseases. Cell Death Differ. 2006, 13:385-392.
99. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993, 364:626-632.
100. Lipton S.A., Choi Y.-B., Takahashi H., Zhang D., Li W., Godzik A., Bankston L.A. Cysteine regulation of protein function-as exemplified by NMDA-receptor modulation. Trends Neurosci. 2002, 25:474-480.
101. Lipton S.A., Nakamura T., Yao D., Shi Z.-Q., Uehara T., Gu Z. Comment on "S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function". Science 2005, 308:1870. author reply 1870.
102. Malito E., Ralat L.A., Manolopoulou M., Tsay J.L., Wadlington N.L., Tang W.J. Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme. Biochemistry 2008, 47:12822-12834.
103. Manabe S., Gu Z., Lipton S.A. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 2005, 46:4747-4753.
104. Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X., Kane L.S., Gow A.J., Stamler J.S. Fas-induced caspase denitrosylation. Science 1999, 284:651-654.
105. Marino S.M., Gladyshev V.N. Structural analysis of cysteine S-nitrosylation:a modified acid-based motif and the emerging role of trans-nitrosylation. J.Mol. Biol. 2010, 395:844-859.
106. Marshall H.E., Stamler J.S. Inhibition of NF-κ B by S-nitrosylation. Biochemistry 2001, 40:1688-1693.
107. Martínez-Ruiz A., Lamas S. Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc. Res. 2007, 75:220-228.
108. Martínez-Ruiz A., Villanueva L., González de Orduña C., López-Ferrer D., Higueras M.A., Tarín C., Rodríguez-Crespo I., Vázquez J., Lamas S. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc. Natl. Acad. Sci. USA 2005, 102:8525-8530.
109. Matsushita K., Morrell C.N., Cambien B., Yang S.X., Yamakuchi M., Bao C., Hara M.R., Quick R.A., Cao W., O'Rourke B., et al. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 2003, 115:139-150.
110. Mattson M.P., Chan S.L., Duan W. Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol. Rev. 2002, 82:637-672.
111. Melino G., Bernassola F., Knight R.A., Corasaniti M.T., Nistico G., Finazzi-Agro A. S-nitrosylation regulates apoptosis. Nature 1997, 388:432-433.
112. Meng F., Yao D., Shi Y., Kabakoff J., Wu W., Reicher J., Ma Y., Moosmann B., Masliah E., Lipton S.A., Gu Z. Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation. Mol. Neurodegener. 2011, 6:34.
113. Meulener M., Whitworth A.J., Armstrong-Gold C.E., Rizzu P., Heutink P., Wes P.D., Pallanck L.J., Bonini N.M. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr. Biol. 2005, 15:1572-1577.
114. Mikkelsen R.B., Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003, 22:5734-5754.
115. Miller R.L., James-Kracke M., Sun G.Y., Sun A.Y. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem. Res. 2009, 34:55-65.
116. Mitchell D.A., Marletta M.A. Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat. Chem. Biol. 2005, 1:154-158.
117. Mitsumoto A., Nakagawa Y., Takeuchi A., Okawa K., Iwamatsu A., Takanezawa Y. Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic. Res. 2001, 35:301-310.
118. Mustafa A.K., Kumar M., Selvakumar B., Ho G.P., Ehmsen J.T., Barrow R.K., Amzel L.M., Snyder S.H. Nitric oxide S-nitrosylates serine racemase, mediating feedback inhibition of D-serine formation. Proc. Natl. Acad. Sci. USA 2007, 104:2950-2955.
119. Nakamura T., Lipton S.A. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding. Cell Death Differ. 2007, 14:1305-1314.
120. Nakamura T., Wang L., Wong C.C., Scott F.L., Eckelman B.P., Han X., Tzitzilonis C., Meng F., Gu Z., Holland E.A., et al. Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. Mol. Cell 2010, 39:184-195.
121. Nathan C., Calingasan N., Nezezon J., Ding A., Lucia M.S., La Perle K., Fuortes M., Lin M., Ehrt S., Kwon N.S., et al. Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J.Exp. Med. 2005, 202:1163-1169.
122. Nott A., Watson P.M., Robinson J.D., Crepaldi L., Riccio A. S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 2008, 455:411-415.
123. Numajiri N., Takasawa K., Nishiya T., Tanaka H., Ohno K., Hayakawa W., Asada M., Matsuda H., Azumi K., Kamata H., et al. On-off system for PI3-kinase-Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN). Proc. Natl. Acad. Sci. USA 2011, 108:10349-10354.
124. Núñez L., Vaquero M., Gómez R., Caballero R., Mateos-Cáceres P., Macaya C., Iriepa I., Gálvez E., López-Farré A., Tamargo J., Delpón E. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc. Res. 2006, 72:80-89.
125. Ohshima T., Ward J.M., Huh C.G., Longenecker G., Veeranna, Pant H.C., Brady R.O., Martin L.J., Kulkarni A.B. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. USA 1996, 93:11173-11178.
126. Ozawa K., Whalen E.J., Nelson C.D., Mu Y., Hess D.T., Lefkowitz R.J., Stamler J.S. S-nitrosylation of β-arrestin regulates beta-adrenergic receptor trafficking. Mol. Cell 2008, 31:395-405.
127. Paige J.S., Xu G., Stancevic B., Jaffrey S.R. Nitrosothiol reactivity profiling identifies S-nitrosylated proteins with unexpected stability. Chem. Biol. 2008, 15:1307-1316.
128. Palmer Z.J., Duncan R.R., Johnson J.R., Lian L.Y., Mello L.V., Booth D., Barclay J.W., Graham M.E., Burgoyne R.D., Prior I.A., Morgan A. S-nitrosylation of syntaxin 1 at Cys(145) is a regulatory switch controlling Munc18-1 binding. Biochem. J. 2008, 413:479-491.
129. Pan Z.H., Segal M.M., Lipton S.A. Nitric oxide-related species inhibit evoked neurotransmission but enhance spontaneous miniature synaptic currents in central neuronal cultures. Proc. Natl. Acad. Sci. USA 1996, 93:15423-15428.
130. Papadia S., Soriano F.X., Léveillé F., Martel M.A., Dakin K.A., Hansen H.H., Kaindl A., Sifringer M., Fowler J., Stefovska V., et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat. Neurosci. 2008, 11:476-487.
131. Park H.S., Huh S.H., Kim M.S., Lee S.H., Choi E.J. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc. Natl. Acad. Sci. USA 2000, 97:14382-14387.
132. Park H.S., Yu J.W., Cho J.H., Kim M.S., Huh S.H., Ryoo K., Choi E.J. Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism. J.Biol. Chem. 2004, 279:7584-7590.
133. Pei D.S., Sun Y.F., Song Y.J. S-nitrosylation of PTEN Invovled in ischemic brain injury in rat hippocampal CA1 region. Neurochem. Res. 2009, 34:1507-1512.
134. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
135. Qu J., Nakamura T., Cao G., Holland E.A., McKercher S.R., Lipton S.A. S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by β-amyloid peptide. Proc. Natl. Acad. Sci. USA 2011, 108:14330-14335.
136. Qu J., Nakamura T., Holland E.A., McKercher S.R., Lipton S.A. S-nitrosylation of Cdk5: potential implications in amyloid-β-related neurotoxicity in Alzheimer disease. Prion 2012, 6:364-370.
137. Ralat L.A., Ren M., Schilling A.B., Tang W.J. Protective role of Cys-178 against the inactivation and oligomerization of human insulin-degrading enzyme by oxidation and nitrosylation. J.Biol. Chem. 2009, 284:34005-34018.
138. Reddy P.H., Beal M.F. Amyloid β, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med. 2008, 14:45-53.
139. + channels in C-type DRG neurons by S-nitrosylation. J.Neurophysiol. 2002, 87:761-775.
140. Rhee S.G., Kang S.W., Jeong W., Chang T.-S., Yang K.-S., Woo H.A. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 2005, 17:183-189.
141. Romero-Puertas M.C., Laxa M., Mattè A., Zaninotto F., Finkemeier I., Jones A.M., Perazzolli M., Vandelle E., Dietz K.J., Delledonne M. S-nitrosylation of peroxiredoxin II E promotes peroxynitrite-mediated tyrosine nitration. Plant Cell 2007, 19:4120-4130.
142. Sarafian T.A., Verity M.A., Vinters H.V., Shih C.C.Y., Shi L., Ji X.D., Dong L., Shau H. Differential expression of peroxiredoxin subtypes in human brain cell types. J.Neurosci. Res. 1999, 56:206-212.
143. Sarkar S., Korolchuk V.I., Renna M., Imarisio S., Fleming A., Williams A., Garcia-Arencibia M., Rose C., Luo S., Underwood B.R., et al. Complex inhibitory effects of nitric oxide on autophagy. Mol. Cell 2011, 43:19-32.
144. Sattler R., Xiong Z., Lu W.Y., Hafner M., MacDonald J.F., Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 1999, 284:1845-1848.
145. Sayre L.M., Perry G., Smith M.A. Oxidative stress and neurotoxicity. Chem. Res. Toxicol. 2008, 21:172-188.
146. Schonhoff C.M., Daou M.C., Jones S.N., Schiffer C.A., Ross A.H. Nitric oxide-mediated inhibition of Hdm2-p53 binding. Biochemistry 2002, 41:13570-13574.
147. Selvakumar B., Huganir R.L., Snyder S.H. S-nitrosylation of stargazin regulates surface expression of AMPA-glutamate neurotransmitter receptors. Proc. Natl. Acad. Sci. USA 2009, 106:16440-16445.
148. Selvakumar B., Jenkins M.A., Hussain N.K., Huganir R.L., Traynelis S.F., Snyder S.H. S-nitrosylation of AMPA receptor GluA1 regulates phosphorylation, single-channel conductance, and endocytosis. Proc. Natl. Acad. Sci. USA 2013, 110:1077-1082.
149. Sen N., Snyder S.H. Neurotrophin-mediated degradation of histone methyltransferase by S-nitrosylation cascade regulates neuronal differentiation. Proc. Natl. Acad. Sci. USA 2011, 108:20178-20183.
150. Sen N., Hara M.R., Kornberg M.D., Cascio M.B., Bae B.I., Shahani N., Thomas B., Dawson T.M., Dawson V.L., Snyder S.H., Sawa A. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat. Cell Biol. 2008, 10:866-873.
151. Sen N., Hara M.R., Ahmad A.S., Cascio M.B., Kamiya A., Ehmsen J.T., Agrawal N., Hester L., Doré S., Snyder S.H., Sawa A. GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation. Neuron 2009, 63:81-91.
152. Seth D., Stamler J.S. The SNO-proteome: causation and classifications. Curr. Opin. Chem. Biol. 2011, 15:129-136.
153. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J.Neurosci. 2007, 27:2866-2875.
154. Shi Z.-Q., Sunico C.R., McKercher S.R., Cui J., Feng G.-S., Nakamura T., Lipton S.A. S-nitrosylated SHP-2 contributes to NMDA receptor-mediated excitotoxicity in acute ischemic stroke. Proc. Natl. Acad. Sci. USA 2013, 110:3137-3142.
155. Shimura H., Hattori N., Kubo Si., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 2000, 25:302-305.
156. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., Greengard P. Regulation of NMDA receptor trafficking by amyloid-β. Nat. Neurosci. 2005, 8:1051-1058.
157. Sriram S.M., Kim B.Y., Kwon Y.T. The N-end rule pathway: emerging functions and molecular principles of substrate recognition. Nat. Rev. Mol. Cell Biol. 2011, 12:735-747.
158. Stamler J.S., Toone E.J. The decomposition of thionitrites. Curr. Opin. Chem. Biol. 2002, 6:779-785.
159. Stamler J.S., Simon D.I., Osborne J.A., Mullins M.E., Jaraki O., Michel T., Singel D.J., Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA 1992, 89:444-448.
160. Stamler J.S., Toone E.J., Lipton S.A., Sucher N.J. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 1997, 18:691-696.
161. Stamler J.S., Lamas S., Fang F.C. Nitrosylation. the prototypic redox-based signaling mechanism. Cell 2001, 106:675-683.
162. Stroissnigg H., Trancíková A., Descovich L., Fuhrmann J., Kutschera W., Kostan J., Meixner A., Nothias F., Propst F. S-nitrosylation of microtubule-associated protein 1B mediates nitric-oxide-induced axon retraction. Nat. Cell Biol. 2007, 9:1035-1045.
163. Sumbayev V.V., Budde A., Zhou J., Brüne B. HIF-1 α protein as a target for S-nitrosation. FEBS Lett. 2003, 535:106-112.
164. Sun J., Morgan M., Shen R.F., Steenbergen C., Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ. Res. 2007, 101:1155-1163.
165. Taira T., Saito Y., Niki T., Iguchi-Ariga S.M.M., Takahashi K., Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2004, 5:213-218.
166. Takahashi H., Shin Y., Cho S.J., Zago W.M., Nakamura T., Gu Z., Ma Y., Furukawa H., Liddington R., Zhang D., et al. Hypoxia enhances S-nitrosylation-mediated NMDA receptor inhibition via a thiol oxygen sensor motif. Neuron 2007, 53:53-64.
167. Tanaka S., Uehara T., Nomura Y. Up-regulation of protein-disulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. J.Biol. Chem. 2000, 275:10388-10393.
168. Tenneti L., D'Emilia D.M., Lipton S.A. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci. Lett. 1997, 236:139-142.
169. Tian J., Kim S.F., Hester L., Snyder S.H. S-nitrosylation/activation of COX-2 mediates NMDA neurotoxicity. Proc. Natl. Acad. Sci. USA 2008, 105:10537-10540.
170. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 2006, 7:833-846.
171. Tsang A.H.K., Lee Y.-I., Ko H.S., Savitt J.M., Pletnikova O., Troncoso J.C., Dawson V.L., Dawson T.M., Chung K.K.K. S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proc. Natl. Acad. Sci. USA 2009, 106:4900-4905.
172. Tsui A.K., Marsden P.A., Mazer C.D., Adamson S.L., Henkelman R.M., Ho J.J., Wilson D.F., Heximer S.P., Connelly K.A., Bolz S.S., et al. Priming of hypoxia-inducible factor by neuronal nitric oxide synthase is essential for adaptive responses to severe anemia. Proc. Natl. Acad. Sci. USA 2011, 108:17544-17549.
173. Uehara T., Nakamura T., Yao D., Shi Z.Q., Gu Z., Ma Y., Masliah E., Nomura Y., Lipton S.A. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006, 441:513-517.
174. Um H.C., Jang J.H., Kim D.H., Lee C., Surh Y.J. Nitric oxide activates Nrf2 through S-nitrosylation of Keap1 in PC12 cells. Nitric Oxide 2011, 25:161-168.
175. Walker A.K., Farg M.A., Bye C.R., McLean C.A., Horne M.K., Atkin J.D. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis. Brain 2010, 133:105-116.
176. Wang H.Q., Takahashi R. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease. Antioxid. Redox Signal. 2007, 9:553-561.
177. Wang J., Liu S., Fu Y., Wang J.H., Lu Y. Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat. Neurosci. 2003, 6:1039-1047.
178. Wang G., Moniri N.H., Ozawa K., Stamler J.S., Daaka Y. Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc. Natl. Acad. Sci. USA 2006, 103:1295-1300.
179. Wang X., Su B., Lee H.G., Li X., Perry G., Smith M.A., Zhu X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J.Neurosci. 2009, 29:9090-9103.
180. Wang S., Song J., Tan M., Albers K.M., Jia J. Mitochondrial fission proteins in peripheral blood lymphocytes are potential biomarkers for Alzheimer's disease. Eur. J. Neurol. 2012, 19:1015-1022.
181. Whalen E.J., Foster M.W., Matsumoto A., Ozawa K., Violin J.D., Que L.G., Nelson C.D., Benhar M., Keys J.R., Rockman H.A., et al. Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 2007, 129:511-522.
182. Wilcock D.M., Lewis M.R., Van Nostrand W.E., Davis J., Previti M.L., Gharkholonarehe N., Vitek M.P., Colton C.A. Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2. J.Neurosci. 2008, 28:1537-1545.
183. Xu L., Han C., Lim K., Wu T. Activation of cytosolic phospholipase A2alpha through nitric oxide-induced S-nitrosylation. Involvement of inducible nitric-oxide synthase and cyclooxygenase-2. J.Biol. Chem. 2008, 283:3077-3087.
184. Xue Y., Liu Z., Gao X., Jin C., Wen L., Yao X., Ren J. GPS-SNO: computational prediction of protein S-nitrosylation sites with a modified GPS algorithm. PLoS ONE 2010, 5:e11290.
185. Yao D., Gu Z., Nakamura T., Shi Z.Q., Ma Y., Gaston B., Palmer L.A., Rockenstein E.M., Zhang Z., Masliah E., et al. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc. Natl. Acad. Sci. USA 2004, 101:10810-10814.
186. Yasinska I.M., Sumbayev V.V. S-nitrosation of Cys-800 of HIF-1α protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett. 2003, 549:105-109.
187. Yasukawa T., Tokunaga E., Ota H., Sugita H., Martyn J.A., Kaneki M. S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J.Biol. Chem. 2005, 280:7511-7518.
188. Yonashiro R., Kimijima Y., Shimura T., Kawaguchi K., Fukuda T., Inatome R., Yanagi S. Mitochondrial ubiquitin ligase MITOL blocks S-nitrosylated MAP1B-light chain 1-mediated mitochondrial dysfunction and neuronal cell death. Proc. Natl. Acad. Sci. USA 2012, 109:2382-2387.
189. Yoshida T., Inoue R., Morii T., Takahashi N., Yamamoto S., Hara Y., Tominaga M., Shimizu S., Sato Y., Mori Y. Nitric oxide activates TRP channels by cysteine S-nitrosylation. Nat. Chem. Biol. 2006, 2:596-607.
190. Youle R.J., van der Bliek A.M. Mitochondrial fission, fusion, and stress. Science 2012, 337:1062-1065.
191. Zecca L., Youdim M.B., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 2004, 5:863-873.
192. Zhang J., Jin B., Li L., Block E.R., Patel J.M. Nitric oxide-induced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung endothelial cells. Am. J. Physiol. Cell Physiol. 2005, 288:C840-C849.
193. Zhang P., Yu P.C., Tsang A.H., Chen Y., Fu A.K., Fu W.Y., Chung K.K., Ip N.Y. S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development. J.Neurosci. 2010, 30:14366-14370.